Corporate insider profile

Roy D. Baynes Filing Activity

Latest reported as Director of Travere Therapeutics, Inc. (TVTX).

Purchase filings: 0
Reported companies: 1
Net open-market value: -$2,218,199.60
Latest transaction: Jun 12, 2026

Affiliated corporations

Reported company relationships

TVTXLatest reported

Travere Therapeutics, Inc.

Director

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
Date	Company	Role	Type	Shares	Price	Total value
Jun 12, 2026	Travere Therapeutics, Inc. (TVTX)	Director	Sale	4,500	$50.00	$225,000
May 5, 2026	Travere Therapeutics, Inc. (TVTX)	Director	Sale	4,500	$46.65	$209,925
May 1, 2026	Travere Therapeutics, Inc. (TVTX)	Director	Sale	9,750	$44.22	$431,145
Jun 18, 2026	Executive Name	Chief Financial Officer	Sale	00,000	$00.00	$0,000,000
May 29, 2026	Executive Name	Director	Sale	0,000	$00.00	$000,000

Subscribe to see more data